| BFK501-Biopharmaceutics | 3 | 2 | 1 | 0 | 2 | 1 | 1 | 2 | 1 | 2 |
| BFK502-Pharmacokinetics | 3 | 2 | 1 | 0 | 2 | 1 | 1 | 2 | 1 | 2 |
| BFK503-Pharmaceutical Dissolution Rate | 3 | 2 | 1 | 0 | 2 | 1 | 1 | 2 | 1 | 2 |
| BFK505-Dosage Forms and Bioavailability | 3 | 2 | 1 | 0 | 2 | 1 | 1 | 2 | 1 | 2 |
| BFK506-Pharmaceutical Dissolution Rate Applications | 3 | 2 | 1 | 0 | 2 | 1 | 1 | 2 | 1 | 2 |
| BFK507-Bioavailability and Bioequivalence | 3 | 2 | 1 | 0 | 2 | 1 | 1 | 2 | 1 | 2 |
| BFK508-Pharmaceutical Parameters Affecting Bioavailability | 3 | 3 | 1 | 0 | 0 | 2 | 0 | 0 | 1 | 0 |
| TEZ700-Thesis | | | | | | | | | | |
| UZM700-Research in Area of Specialization | | | | | | | | | | |